U.S. Government Shutdown Freezes Billions in Deals as Businesses Wait on Washington
Oct 5, 2025
05:49
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
The federal shutdown is stalling IPOs, mergers, and drug approvals as agencies like the SEC and FDA grind to a halt. Companies across biotech, energy, and finance face costly delays with billions in growth trapped in limbo.